摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

μ-oxo-bis[bromotris(p-methylphenyl)antimony(V)] | 85362-44-3

中文名称
——
中文别名
——
英文名称
μ-oxo-bis[bromotris(p-methylphenyl)antimony(V)]
英文别名
μ-oxobis(bromotris(p-tolyl)antimony(V));bromo-[bromo-tris(4-methylphenyl)-λ5-stibanyl]oxy-tris(4-methylphenyl)-λ5-stibane
μ-oxo-bis[bromotris(p-methylphenyl)antimony(V)]化学式
CAS
85362-44-3
化学式
C42H42Br2OSb2
mdl
——
分子量
966.103
InChiKey
QQVRBPBANLBCGF-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.88
  • 重原子数:
    47.0
  • 可旋转键数:
    8.0
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    9.23
  • 氢给体数:
    0.0
  • 氢受体数:
    1.0

反应信息

  • 作为反应物:
    描述:
    sodium hydroxide 、 μ-oxo-bis[bromotris(p-methylphenyl)antimony(V)]氘代氯仿 为溶剂, 生成
    参考文献:
    名称:
    Oxygen bridged hexa(organo)di-antimony compounds: Hydrolysis by traces of moisture and crystal structures of [SbR3Br]2O, where R = p- or o-tolyl
    摘要:
    H-1 and C-13 NMR spectroscopy of four compounds of the type [SbR3X](2)O, where X = Br and R = Ph, p-tolyl and o-tolyl or X = Cl and R = Me, have been interpreted as showing that unless stringent precautions are taken to exclude moisture there is cleavage of the oxygen bridge to give solutions which contain both the hydroxo species, SbR3(OH)X, and the original bridged compound. This is in agreement with earlier results from IR spectra of compounds of this type in the presence of water. Rigorous exclusion of moisture leads to NMR spectra of only the unhydrolysed compound and this is the only product isolated when NMR solutions showing the presence of both compounds are crystallised. On the other hand, a stable hydroxobromide, Sb(mesityl)(3)Br(OH), has been isolated from hydrolysis of Sb(mesityl)(3)Br-2. Crystal structures are reported for the o- and p-tolyl isomers of [Sb(tolyl)(3)Br](2)O; the latter has crystallographically imposed 3 symmetry with a linear Sb-O-Sb bridge but the two independent molecules of the o-tolyl derivative have bridge angles of 161.0(2) and 171.5(2)degrees, respectively. (C) 1997 Elsevier Science S.A.
    DOI:
    10.1016/s0022-328x(97)00208-8
  • 作为产物:
    描述:
    sodium hydroxide 、 甲醇三(对甲基苯基)二溴化锑甲醇 为溶剂, 以76%的产率得到μ-oxo-bis[bromotris(p-methylphenyl)antimony(V)]
    参考文献:
    名称:
    Oxygen bridged hexa(organo)di-antimony compounds: Hydrolysis by traces of moisture and crystal structures of [SbR3Br]2O, where R = p- or o-tolyl
    摘要:
    H-1 and C-13 NMR spectroscopy of four compounds of the type [SbR3X](2)O, where X = Br and R = Ph, p-tolyl and o-tolyl or X = Cl and R = Me, have been interpreted as showing that unless stringent precautions are taken to exclude moisture there is cleavage of the oxygen bridge to give solutions which contain both the hydroxo species, SbR3(OH)X, and the original bridged compound. This is in agreement with earlier results from IR spectra of compounds of this type in the presence of water. Rigorous exclusion of moisture leads to NMR spectra of only the unhydrolysed compound and this is the only product isolated when NMR solutions showing the presence of both compounds are crystallised. On the other hand, a stable hydroxobromide, Sb(mesityl)(3)Br(OH), has been isolated from hydrolysis of Sb(mesityl)(3)Br-2. Crystal structures are reported for the o- and p-tolyl isomers of [Sb(tolyl)(3)Br](2)O; the latter has crystallographically imposed 3 symmetry with a linear Sb-O-Sb bridge but the two independent molecules of the o-tolyl derivative have bridge angles of 161.0(2) and 171.5(2)degrees, respectively. (C) 1997 Elsevier Science S.A.
    DOI:
    10.1016/s0022-328x(97)00208-8
点击查看最新优质反应信息

文献信息

  • Multiply bridged organodiantimony(V) compounds; crystal structures of [(SbR2)2(μ-O)2(μ -O2AsMe2)2] (R = Ph or p-tolyl) and [(SbR3)2(μ-O)(μ-O2 MR′2)2] (R = Ph, M = P, R′ = Me; R = Ph, M = As, R′ = Me or Ph; R = p-tolyl, M = P, R′ = Me)
    作者:Martin N. Gibbons、D. Bryan Sowerby
    DOI:10.1039/a702244a
    日期:——
    A number of quadruply and triply bridged organodiantimony(V) compounds have been synthesized by reactions of [(SbR 2 BrO) 2 ] (R = Ph or p-tolyl) and [(SbR 3 X) 2 O] (R = Ph or p-tolyl, X = Br or Cl) with Na(O 2 AsMe 2 ), Na(O 2 AsPh 2 ) or Na(O 2 AsMe 2 ). The compounds have been characterised by a range of spectroscopic methods and crystal structures are reported for two quadruply bridged, [(SbPh 2 ) 2 (µ-O) 2 (µ -O 2 AsMe 2 ) 2 ] and [Sb(p-MeC 6 H 4 ) 2 } 2 (µ-O) 2 (µ-O 2 AsMe 2 ) 2 ], and four triply bridged compounds, [(SbPh 3 ) 2 (µ-O)(µ-O 2 PMe 2 ) 2 ], [(SbPh 3 ) 2 (µ-O)(µ-O 2 AsMe 2 ) 2 ], [(SbPh 3 ) 2 (µ-O)(µ-O 2 AsPh 2 ) 2 ] and [Sb(p-MeC 6 H 4 ) 3 } 2 (µ-O)(µ-O 2 PMe 2 ) 2 ]. Related trimethylantimony(V) compounds, i.e. [SbMe 3 (O 2 PMe 2 )} 2 O] and [SbMe 3 (O 2 AsPh 2 )} 2 O], which are highly moisture sensitive, have also been obtained.
    通过[(SbR₂BrO)₂] (R = Ph 或 p-tolyl) 和 [(SbR₃X)₂O] (R = Ph 或 p-tolyl, X = Br 或 Cl) 与 Na(O₂AsMe₂)、Na(O₂AsPh₂) 或 Na(O₂AsMe₂) 的反应,合成了多种四重和三重桥连的组织二(V)化合物。这些化合物通过一系列光谱方法进行了表征,并报道了两种四重桥连化合物 [(SbPh₂)₂(µ-O)₂(µ-O₂AsMe₂)₂] 和 [Sb(p-MeC₆H₄)₂}₂(µ-O)₂(µ-O₂AsMe₂)₂],以及四种三重桥连化合物 [(SbPh₃)₂(µ-O)(µ-O₂PMe₂)₂]、[(SbPh₃)₂(µ-O)(µ-O₂AsMe₂)₂]、[(SbPh₃)₂(µ-O)(µ-O₂AsPh₂)₂] 和 [Sb(p-MeC₆H₄)₃}₂(µ-O)(µ-O₂PMe₂)₂] 的晶体结构。还获得了高度吸湿性的相关三甲基锑(V)化合物,即 [SbMe₃(O₂PMe₂)}₂O] 和 [SbMe₃(O₂AsPh₂)}₂O]。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫